Associate Professor of Medicine, University Tex Houston
Oncology
Dr. Abenaa M. Brewster, MD
|
|
Give Review
Doctor Abenaa M. Brewster, MD works in the field of Oncology. He researched medicine at Harvard Medical School. Harvard Medical School is one of the top medical schools in the US. Harvard Medical School is ranked 1 in research and 12 in primary care medicine He received awards:"Regional Top Doctor". Abenaa Brewster is a published MD as well. He has 61 publications published. The latest was: Epidemiological risk factors associated with inflammatory breast cancer subtypes. Abenaa Brewster accepts all Medicare patients.
Publications
- Epidemiological risk factors associated with inflammatory breast Cancer subtypes.
- Acculturation, Behavioral Factors, and Family History of Breast Cancer among Mexican and Mexican-American Women.
- Epidemiology, biology, and treatment of triple-negative breast Cancer in women of African ancestry.
- Association between germline single nucleotide polymorphisms in the PI3K-AKT-mTOR pathway, obesity, and breast Cancer disease-free survival.
- Sexual Problems During the First 2 Years of Adjuvant Treatment with Aromatase Inhibitors.
- Loss of LRIG1 Locus Increases Risk of Early and Late Relapse of Stage I/II Breast Cancer.
- Telemedicine and telesurgery in Cancer care: Inaugural conference at MD Anderson Cancer Center.
- Cost of Contralateral Prophylactic Mastectomy.
- Open label randomized clinical trial of standard neoadjuvant chemotherapy with paclitaxel followed by FEC vs. the combination of paclitaxel and everolimus followed by ...
- Genomic copy number imbalances associated with bone and non-bone metastasis of early-stage breast Cancer.
- Reproductive and Hormonal Risk Profile According to Language Acculturation and Country of Residence in the Ella Binational Breast Cancer Study.
- Ethnic disparities in adherence to breast Cancer survivorship surveillance care.
- Genetic variant rs16430 6bp > 0bp at the microRNA-binding site in TYMS and risk of sporadic breast Cancer risk in non-hispanic white women aged ≤55 years.
- An Open-Label Safety Study of Lapatinib Plus Trastuzumab Plus Paclitaxel in First-Line HER2-Positive Metastatic Breast Cancer.
- Association between parity and obesity in Mexican and Mexican-American women: findings from the ella binational breast Cancer study.
- Prognostic value of single nucleotide polymorphisms of candidate genes associated with inflammation in early stage breast Cancer.
- Hypothesized role of pregnancy hormones on HER2+ Breast tumor development.
- Genetic variants in the vitamin D pathway and breast Cancer disease-free survival.
- Impact of race and ethnicity on features and outcome of ductal carcinoma in situ of the Breast.
- Biologic features and prognosis of ductal Carcinoma in situ are not adversely impacted by initial large body mass.
- Association between contralateral prophylactic mastectomy and breast Cancer outcomes by hormone receptor status.
- Gamma-ray-induced mutagen sensitivity and risk of sporadic breast Cancer in young women: a case-control study.
- Short -term biomarker modulation prevention study of Anastrozole in Women at increased risk for second primary breast Cancer.
- Copy Number Imbalances Between Screen and Symptom-Detected Breast Cancers and Impact on Disease-free Survival.
- Current Knowledge on Contralateral Prophylactic Mastectomy Among Women with Sporadic Breast Cancer.
- Selective genomic copy number imbalances and probability of recurrence in early-stage breast Cancer.
- What can we learn about disease etiology from case-case analyses? Lessons from breast Cancer.
- Conference Report: Eighth Annual AACR International Conference on Frontiers in Cancer Prevention Research.
- Ductal Carcinoma in situ: state of the science and roadmap to advance the field.
- Phase I/II study of G3139 (Bcl-2 antisense oligonucleotide) in combination with doxorubicin and docetaxel in breast Cancer.
- Relationship between obesity and pathologic response to neoadjuvant chemotherapy among women with operable breast Cancer.
- Residual risk of breast Cancer recurrence 5 years after adjuvant therapy.
- Relationship between epidemiologic risk factors and breast Cancer recurrence.
- Randomized trial of adjuvant 13-cis-retinoic acid and interferon alfa for patients with aggressive skin squamous cell Carcinoma.
- Breast carcinoma chemoprevention in the community setting. Estimating risks and benefits.
- XPD polymorphism and risk of subsequent Cancer in individuals with nonmelanoma skin Cancer.
- Association of Body Mass Index Changes during Neoadjuvant Chemotherapy with Pathologic Complete Response and Clinical Outcomes in Patients with Locally Advanced Breast...
- Better contralateral breast Cancer risk estimation and alternative options to contralateral prophylactic mastectomy.
- Family history of breast and ovarian Cancer and triple negative subtype in hispanic/latina women.
- The functional promoter polymorphism (-842G>C) in the PIN1 gene is associated with decreased risk of breast Cancer in non-Hispanic white women 55 years and younger.
- Genetic variants in the H2AFX promoter region are associated with risk of sporadic breast Cancer in non-Hispanic white women aged
- Repair capacity for UV light induced DNA damage associated with risk of nonmelanoma skin Cancer and tumor progression.
- Phase 3 study comparing the use of docetaxel on an every-3-week versus weekly schedule in the treatment of metastatic breast Cancer.
- Polymorphisms of the DNA repair genes XPD (Lys751Gln) and XRCC1 (Arg399Gln and Arg194Trp): relationship to breast Cancer risk and familial predisposition to breast can...
- Reduced DNA repair of benzo[a]pyrene diol epoxide-induced adducts and common XPD polymorphisms in breast Cancer patients.
- Promoter polymorphism (-786t>C) in the endothelial nitric oxide synthase gene is associated with risk of sporadic breast Cancer in non-Hispanic white women age younger...
- The impact of obesity on receipt of adjuvant chemotherapy for breast Cancer in the National Comprehensive Cancer Network (NCCN) centers.
- A review of body size and breast Cancer risk in Hispanic and African American women.
- Conference Report: Seventh Annual AACR International Conference on Frontiers in Cancer Prevention Research.
- Factors that influence mammography use and breast Cancer detection among Mexican-American and African-American women.
- The reliability of nipple aspirate and ductal lavage in women at increased risk for breast Cancer--a potential tool for breast Cancer risk assessment and biomarker eva...
- Polymorphisms and haplotypes of the NBS1 gene are associated with risk of sporadic breast Cancer in non-Hispanic white women
- Comparison of ductal lavage and random periareolar fine needle aspiration as tissue acquisition methods in early breast Cancer prevention trials.
- Building a predictive breast Cancer risk model.
- Breast Cancer epidemiology, prevention, and early detection.
- Tumor-suppressor activity of RRIG1 in breast Cancer.
- Small cell lung Cancer treated in southeast Wales.
- Pilot study of preoperative combined modality treatment for locally advanced operable oesophageal Carcinoma: toxicities and long-term outcome.
- A prospective comparison of multidisciplinary treatment of oesophageal Cancer with curative intent in a UK Cancer network.
- The Relationship Between Eight GWAS-Identified Single-Nucleotide Polymorphisms and Primary Breast Cancer Outcomes.
Schools
HARVARD MED SCH
Procedures Preformed
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- Thoracentesis
Conditions Treated
- Adrenal Gland Cancer
- Anemia
- Breast Cancer
- Carcinoma in Situ
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
- Choice Plus POS II
- Amerigroup (Wellpoint)
- Blue Card PPO
- Blue Choice
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- Commercial Insurance Company
- CoreSource
- First Health (Coventry Health Care) PPO
- Golden Rule
- GEHA
- Choice Care PPO
- Medical Mutual of Ohio
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Awards
- Regional Top Doctor
Education
-
Johns Hopkins University -
Harvard Medical School
Hospital
-
University of Texas M.D. Anderson Cancer Center
Drug Facts
| NPI NUMBER | 1346331063 | |
| NPPES Provider LastName | BREWSTER | |
| NPPES Provider FirstName | ABENAA | |
| NPPES Provider ZIPCode | 770304009 | |
| NPPES Provider State | TX | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 192.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1346331063 |
| Last Name Of The Provider | BREWSTER |
| First Name Of The Provider | ABENAA |
| View All |
Similar Doctors
|
|
Dr. Maria A. Zarzour, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sao Jiralerspong, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jenny C. Chang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Antonio C. Buzaid, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|